MIT's Claim Construction Prevails In ImClone Suit
A judge handed down a favorable ruling on Tuesday for the Massachusetts Institute of Technology and pharmaceutical company Repligen Corp., largely adopting their proposed claim construction in their heated patent dispute...To view the full article, register now.
Already a subscriber? Click here to view full article